Vaccin- and biotechnology company Abera Bioscience says that the company has conducted a successful preclinical study in ferrets with its nasal vaccine candidate against influenza.According to the company, the results were very strong and matched the best hopes. However, no detailed data are being released at present because the company is preparing a scientific manuscript for publication. The results will, however, be able to be presented to potential partners under confidentiality agreements.